CATALOGO DEI PRODOTTI DELLA RICERCA

IDOLAZZI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.724
EU - Europa 8.703
AS - Asia 6.091
SA - Sud America 847
AF - Africa 172
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 9
Totale 25.560
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.541
RU - Federazione Russa 3.023
SG - Singapore 2.333
GB - Regno Unito 2.155
CN - Cina 1.949
IT - Italia 915
BR - Brasile 668
DE - Germania 641
SE - Svezia 486
VN - Vietnam 473
HK - Hong Kong 450
FR - Francia 432
IE - Irlanda 393
FI - Finlandia 268
KR - Corea 186
BD - Bangladesh 173
IN - India 118
JP - Giappone 101
TR - Turchia 101
CA - Canada 95
UA - Ucraina 90
AR - Argentina 73
NL - Olanda 71
MX - Messico 51
PL - Polonia 43
ZA - Sudafrica 43
NG - Nigeria 42
ES - Italia 36
ID - Indonesia 36
BE - Belgio 31
AT - Austria 30
EC - Ecuador 27
IQ - Iraq 25
CO - Colombia 20
RO - Romania 20
UZ - Uzbekistan 19
SA - Arabia Saudita 17
VE - Venezuela 17
EG - Egitto 16
IR - Iran 14
CL - Cile 13
PK - Pakistan 13
KE - Kenya 12
MA - Marocco 12
PE - Perù 12
AU - Australia 10
BJ - Benin 10
PY - Paraguay 10
PH - Filippine 8
AE - Emirati Arabi Uniti 7
JM - Giamaica 7
NP - Nepal 7
QA - Qatar 7
AZ - Azerbaigian 6
CH - Svizzera 6
CZ - Repubblica Ceca 6
ET - Etiopia 6
GR - Grecia 6
IL - Israele 6
LT - Lituania 6
SN - Senegal 6
AL - Albania 5
CR - Costa Rica 5
JO - Giordania 5
NO - Norvegia 5
TN - Tunisia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EU - Europa 4
HR - Croazia 4
KG - Kirghizistan 4
LB - Libano 4
MY - Malesia 4
PA - Panama 4
SV - El Salvador 4
TG - Togo 4
AM - Armenia 3
BG - Bulgaria 3
BY - Bielorussia 3
DK - Danimarca 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
PT - Portogallo 3
RS - Serbia 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
AF - Afghanistan, Repubblica islamica di 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
BW - Botswana 2
CU - Cuba 2
GT - Guatemala 2
HN - Honduras 2
IS - Islanda 2
LV - Lettonia 2
OM - Oman 2
Totale 25.524
Salva come PNG Salva come JPEG
Città #
Southend 1.927
Dallas 1.577
Singapore 1.273
Ashburn 1.069
Moscow 1.019
Chandler 942
San Jose 853
Jacksonville 472
Hong Kong 438
Dublin 392
Woodbridge 390
Ann Arbor 315
Beijing 309
Verona 292
The Dalles 274
Council Bluffs 246
Houston 217
Los Angeles 176
New York 174
Lawrence 160
Princeton 160
Wilmington 155
Ho Chi Minh City 151
Jinan 145
Bologna 132
Redmond 128
Shenyang 127
Nanjing 122
Hanoi 107
Helsinki 97
Tokyo 90
Buffalo 86
Munich 83
Hebei 73
Tianjin 73
São Paulo 67
Milan 59
Redondo Beach 57
Zhengzhou 56
Santa Clara 55
Changsha 52
Haikou 51
Ningbo 51
Columbus 45
Sindelfingen 43
Taizhou 43
Hangzhou 42
Guangzhou 41
Orem 41
Rome 41
Abuja 40
Chicago 39
Taiyuan 39
Nanchang 38
San Francisco 36
Warsaw 36
Montreal 35
Redwood City 34
Jiaxing 32
Denver 31
London 31
Atlanta 28
Brooklyn 28
Seattle 28
Toronto 27
Brussels 26
Turku 26
Johannesburg 25
Norwalk 25
Boardman 24
Lanzhou 24
Fuzhou 23
Hyderabad 23
Washington 23
Amsterdam 22
Da Nang 22
Düsseldorf 21
Chennai 20
Manchester 20
Phoenix 20
Rio de Janeiro 20
Brasília 19
Dearborn 19
Frankfurt am Main 19
Mexico City 19
Vienna 19
Poplar 18
Sanayi 18
Stockholm 18
Tashkent 18
Haiphong 17
Lancaster 17
Venice 17
Belo Horizonte 15
Falls Church 15
Jakarta 15
Nürnberg 15
Orani 15
Porto Alegre 15
Boston 14
Totale 16.176
Salva come PNG Salva come JPEG
Nome #
Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients 398
Teriparatide and denosumab combination therapy and skeletal metabolism 348
First-line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING-SIR registry 338
A new instrument for the screening of psoriatic arthritis among psoriatic patients 334
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 255
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 254
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 245
Bone metabolism in patients with anorexia nervosa and amenorrhoea 226
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 222
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 215
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 214
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 214
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 210
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 210
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 209
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 208
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 207
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 207
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 206
Bone involvement and osteoporosis in mastocytosis. 203
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 203
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 201
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 201
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 198
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 196
Prevalence and incidence of rheumatoid arthritis in Italy. 191
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 191
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 191
Bone involvement in patient with clonal mast cell disorders 190
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 190
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 188
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 187
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 187
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 187
Could γ\δ T-cells explain zoledronic acid adverse events? 186
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 184
Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: a prospective observational multicentre study (MODERATE) 183
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 182
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 181
The obesity paradox and osteoporosis 179
Osteopetrosi 177
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 176
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 176
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 171
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 170
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 170
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 167
DXA bone mineral density in males: retrospective study in real life. 166
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 165
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 165
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 165
Sclerostin and DKK1 in primary hyperparathyroidism. 164
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 164
Effects of denosumab on peripheral lymphocyte subpopulations 163
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 162
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 161
The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 161
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis 160
Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis 159
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 158
Prevalence of osteoporosis in patients affected by mastocytosis 157
Correction to: The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 157
Development and First Validation of a Disease Activity Score for Gout 156
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 155
Suboptimal methotrexate use in rheumatoid arthritis patients in Italy: the MARI study 154
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 154
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 153
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 152
Periostin: The bone and beyond 152
Improvements in the management of rheumatic patients from vertebral imagee obtained through dual-energy X-ray absorptiometry. 151
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 151
Surgical Treatment of Symptomatic Aortic Aneurysm in a Patient with Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis: Case Report and Review of the Literature 151
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 150
Drug-induced osteonecrosis of the jaw: the state of the art 150
Operator-independent quantitative chest computed tomography versus standard assessment of interstitial lung disease related to systemic sclerosis: A multi-centric study 150
Relationship Between Increased Fecal Calprotectin Levels and Interstitial Lung Disease in Systemic Sclerosis 149
Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study. 146
Focal bone involvement in inflammatory arthritis: the role of IL17 146
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 146
Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID) 146
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis 143
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 143
Effects of secukinumab on serum adipocytokines: preliminary data 143
Vitamin D levels in patients with psoriasis with or without arthritis 142
Rheumatoid arthritis, γδ T cells and bisphosphonates 142
Predictors, Risk Factors, and Incidence Rates of Psoriatic Arthritis Development in Psoriasis Patients: A Systematic Literature Review and Meta-Analysis 140
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 139
Duration of treatment for osteoporosis 139
Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃. 138
Permanent Discontinuation of Glucocorticoids in Polymyalgia Rheumatica is Uncommon but May Be Enhanced by Amino Bisphosphonates 138
Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides? 138
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 137
Could nail and joint alterations make the difference between psoriatic arthritis and osteoarthritis during the ultrasonographic evaluation of the distal interphalangeal joints? 136
Vitamin D status in patients with chronic plaque psoriasis 135
Quantitative chest computed tomography is associated with two prediction models of mortality in interstitial lung disease related to systemic sclerosis 135
The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritis 134
Enthesitis of the hands in psoriatic arthritis: an ultrasonographic perspective 134
Strong relationship between vitamin D status and bone mineral density in anorexia nervosa 134
Ruolo della vitamina D 133
MEDAL con etoricoxib: l’inizio di una nuova era per il trattamento del dolore muscolo scheletrico 133
Totale 17.821
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.933
article - articoli 83.826
book - libri 0
conference - conferenze 670
curatela - curatele 0
other - altro 437
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 169.866
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202143 0 0 0 0 0 0 0 0 0 0 0 43
2021/20221.206 93 347 7 62 54 29 24 65 81 24 85 335
2022/20232.688 191 289 242 491 213 650 45 145 291 30 76 25
2023/20241.251 54 113 107 152 158 180 60 126 6 37 189 69
2024/20253.160 152 221 152 493 145 111 163 147 472 262 282 560
2025/202611.528 720 506 1.661 1.661 2.545 710 1.060 554 791 612 267 441
Totale 25.910